Search results
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks via Yahoo Finance· 6 days agoCRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims...
3 Cheap Biotech Stocks to Buy Now: May 2024
InvestorPlace· 19 hours agoThe biotech industry is notably risky, but can produce stocks that see massive gains within a day. Well, many of these companies depend on FDA approval...
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
GuruFocus.com via Yahoo Finance· 5 days agoThe details were released through an 8-K filing. This announcement comes in the wake of a...
Catalyst Pharmaceuticals Stock Clears Technical Benchmark With 83 RS Rating
Investor's Business Daily· 14 hours agoOver 100 years of market history reveals that the stocks that go on to make the biggest gains tend...
Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers
Investor's Business Daily· 6 days agoThe stock market rally had a quiet session for a second straight day. Nvidia fell slightly for a...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 19 hours agoCasgevy was developed in a partnership with Vertex Pharmaceuticals, which seems to be valuable for...
CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast
GuruFocus.com via Yahoo Finance· 5 days agoThis financial stability supports the company's ongoing and future R&D efforts. Strategic Collaborations and Future Directions The company continues to benefit from its strategic collaboration ...
Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
Insider Monkey via Yahoo Finance· 7 days agoIn this article, we will discuss the 10 stocks whose price targets were recently raised by analysts....
Remembering Quant King Jim Simons
GuruFocus.com via Yahoo Finance· 2 days agoOther notable top stocks that have had a long-term, continuous presence in the equity portfolio include VeriSign Inc. (NASDAQ:VRSN) and Vertex ...
How Editas 'dragged' Linda Burkly over as CSO after 37 years at Biogen
FierceBiotech· 5 days agoLinda Burkly, Ph.D., was 37 years into a career at Biogen when Editas Medicines CEO Gilmore...
